Skip to nav Skip to content

COVID-19 Expanded Resource Center

Facebook Twitter LinkedIn Email

Clinical Guidelines & Guidance 

Guidelines

Guidance

Back to Top


Pharmacologic interventions 

Remdesivir

Tocilizumab/IL-6 inhibitors   

Immune modulators

Steroids/Dexamethasone 

Interferons

Convalescent Plasma

Therapeutics Under Early Investigation

Back to Top


Non-pharmacologic interventions

Proning

Back to Top


Diagnostics

Diagnostic Testing

Antibody Testing

Back to Top


Disease Manifestations & Complications

Coagulation

Co-infections 

Post-Acute Care & Issues

Immunology  

Neurology

Back to Top


Vaccines

Vaccine Development

Back to Top


Special Populations & Settings 

Intensive Care

HCT

  • HCT Guidelines 
    Guidelines from the American Society for Transplantation and Cellular Therapy. 

Cancer

Cardiac

  • Cardiac Guidance 
    Clinical guidance and practice updates from the American College of Cardiology. 
  • Using RAAS Antagonists in COVID-19 
    Joint statement from the ACC, American Heart Association and Heart Failure Society of America on renin angiotensin aldosterone system antagonists. 

Pediatric 

Prenatal

HIV

Substance Use Disorder

Transplant

Back to Top


Research & Journals 

Registries

Clinical Trials 

Research Opportunities

Back to Top


Workplace Health & Safety 

Mental Health

Personal Protective Equipment 

Back to Top


Practice Resources/Telehealth 

Telehealth/Telemedicine 

Coverage & Payment 

Back to Top


News, Policy & Advocacy 

Disparities

Public Safety

Advocacy 

Back to Top

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.